找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biomarkers for Huntington‘s Disease; Improving Clinical O Elizabeth A. Thomas,Georgia M. Parkin Book 2023 The Editor(s) (if applicable) and

[復(fù)制鏈接]
查看: 20551|回復(fù): 50
樓主
發(fā)表于 2025-3-21 17:50:24 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Biomarkers for Huntington‘s Disease
期刊簡稱Improving Clinical O
影響因子2023Elizabeth A. Thomas,Georgia M. Parkin
視頻videohttp://file.papertrans.cn/188/187798/187798.mp4
發(fā)行地址Presents the latest advances in the development of digital biomarkers for use in Huntington’s disease.Reviews the current status of fluid biomarkers for Huntington‘s disease.Explores the function of b
學(xué)科分類Contemporary Clinical Neuroscience
圖書封面Titlebook: Biomarkers for Huntington‘s Disease; Improving Clinical O Elizabeth A. Thomas,Georgia M. Parkin Book 2023 The Editor(s) (if applicable) and
影響因子Huntington’s disease (HD) is a fatal, inherited, neurodegenerative disorder, characterized by chorea, motor instabilities, psychiatric manifestations and cognitive decline. Early genetic testing provides an opportunity for clinical interventions aimed at delaying onset and/or slowing progression of disease; however, current treatments for HD are limited, with only two FDA-approved drugs available to manage chorea. Encouragingly, however, several disease-modifying treatment approaches are in the therapeutic pipeline, with more than 200 clinical studies, and many more preclinical studies, in the works. Robust and reliable biomarkers are needed to predict disease onset, monitor disease progression and assess treatment responses. More specifically, biomarkers to stratify patients for clinical trials and biomarkers to track drug efficacy will certainly lead to improved clinical trial design and success. This book represents the first book focused solely on biomarkers for HD and represents adistinct resource that will be informative, not only for clinicians and those involved in clinical trial design, but also for a wide range of neurodegenerative disease researchers. This edited volume
Pindex Book 2023
The information of publication is updating

書目名稱Biomarkers for Huntington‘s Disease影響因子(影響力)




書目名稱Biomarkers for Huntington‘s Disease影響因子(影響力)學(xué)科排名




書目名稱Biomarkers for Huntington‘s Disease網(wǎng)絡(luò)公開度




書目名稱Biomarkers for Huntington‘s Disease網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biomarkers for Huntington‘s Disease被引頻次




書目名稱Biomarkers for Huntington‘s Disease被引頻次學(xué)科排名




書目名稱Biomarkers for Huntington‘s Disease年度引用




書目名稱Biomarkers for Huntington‘s Disease年度引用學(xué)科排名




書目名稱Biomarkers for Huntington‘s Disease讀者反饋




書目名稱Biomarkers for Huntington‘s Disease讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:45:41 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:23:50 | 只看該作者
,Konflikte in der Wirtschaftsprüfung,with the diagnosis and management of this disorder. This chapter then reviews the different classes of CSF biomarkers that have been studied in HD, including neurotransmitters, amino acids, proteins, metabolites, metals, and microRNAs. CSF levels of mutant huntingtin and neurofilament light chain ar
地板
發(fā)表于 2025-3-22 06:18:14 | 只看該作者
,Konflikte in der Wirtschaftsprüfung,apter will review findings from the literature that have explored saliva as a non-invasive biofluid for biomarker research in Huntington’s disease and have identified factors, such as huntingtin, cortisol, uric acid and cytokines, in saliva that track with features of the disease. These studies offe
5#
發(fā)表于 2025-3-22 09:33:30 | 只看該作者
6#
發(fā)表于 2025-3-22 13:19:25 | 只看該作者
Wolfgang H. C. Junge,Martina Jungedetecting early HD pathophysiology before clinical onset. This chapter will provide an overview of the functional and physiological MRI studies conducted in the premanifest and early-stage HD patients, as well as in preclinical HD models, focusing on discussing the potential of different MRI measure
7#
發(fā)表于 2025-3-22 19:42:56 | 只看該作者
8#
發(fā)表于 2025-3-22 23:05:22 | 只看該作者
9#
發(fā)表于 2025-3-23 03:35:00 | 只看該作者
Konflikte um die Aneignung von Landmutant huntingtin within inflammatory cells have been demonstrated. As circulating markers of inflammation has been shown to mirror brain inflammatory changes in HD, this has raised the possibility that these markers could be useful as markers of disease features. This chapter aims to summarize curr
10#
發(fā)表于 2025-3-23 07:11:00 | 只看該作者
Beitr?ge zum Diversity ManagementHowever, several case reports of individuals with the HTT mutation and ALS-like syndrome suggest potential interactions and involvement of TDP-43 in the pathophysiology and phenotype of some individuals with HD. Investigations into other PolyQ diseases, such as Spinocerebellar Ataxias, have provided
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 14:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
柳河县| 景谷| 本溪市| 辽宁省| 宜城市| 松原市| 兴安县| 汕头市| 酉阳| 荥阳市| 永平县| 黄龙县| 瑞丽市| 曲松县| 三河市| 华阴市| 广德县| 滨海县| 康马县| 长治县| 岑巩县| 鲜城| 石狮市| 沙湾县| 连城县| 娄烦县| 佛教| 洛宁县| 饶阳县| 常山县| 武山县| 淮滨县| 陆良县| 兴隆县| 高密市| 修武县| 合山市| 井研县| 陆丰市| 德化县| 双辽市|